Abstract
Purpose
The aim of this study was to evaluate the results of photodynamic therapy (PDT), using verteporfin, for subfoveal neovascular age-related macular degeneration (ARMD) with retinal angiomatous proliferation (RAP) with pigment epithelial detachment (PED) and/or choroidal neovascularization (CNV).
Methods
In this non-comparative, consecutive, interventional, case series, the data on 21 eyes (19 with stage 2 and two with stage 3 RAP) of 20 patients were reviewed. Serous PED occupied more than 50% of the lesion in 19 eyes. PDT was performed as per TAP protocol. Biomicroscopy and fluorescein and indocyanine-green angiography were performed to evaluate anatomical results and need for retreatment. Changes from baseline in best-corrected visual acuity (BCVA), and complications, were assessed.
Results
A mean of 3.5±0.9 treatments was performed. After 13.7±2.2 months, mean BCVA decreased from 20/80 to 20/174 (P=0.0063). In six eyes (28.6%) BCVA remained stable, whereas in 15 eyes (71.5%) it decreased. Occlusion of RAP and flattening of PED was observed in three (14.2%) eyes, conversion to disciform lesion in one (4.7%), and persistence of PED in 11 eyes (52.3%). One eye (4.7%) evolved to haemorrhagic PED, and one (4.7%) toward stage 3 RAP. A tear in the retinal pigment epithelium (RPE) was observed in four eyes (19%). Eleven (52.3%) showed progression of leakage, six moderate leakage (28.6%), and three (14.2%) absence of leakage.
Conclusions
Timely PDT with verteporfin in the early stages in eyes with smaller lesions has the potential for a beneficial effect on vision, whereas it might worsen the natural course of larger lesions, with most eyes undergoing enlargement, disciform transformation or RPE tear.
Similar content being viewed by others
References
Axer-Siegel R, Bourla D, Priel E, et al (2002) Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization. Ophthalmology 109:1726–1736
Axer-Siegel R, Ehrlich R, Rosenblatt I, et al (2004) Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration. Arch Ophthalmol 122:453–459
Borrillo JL, Sivalingam A, Martidis A, Federman J (2003) Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 121:558–561
Boscia F, Furino C, Sborgia L, Reibaldi M, Sborgia C (2004) Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138:1077–1079
Costa RA, Farah ME, Cardillo JA, et al (2003) Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 23:159–165
Gelisken F, Inhoffen W, Partsch M, et al (2001) Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 131:518–520
Ghazi NG, Jabbour NM, De La Cruz ZC, Green WR (2001) Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy. Retina 21:478–486
Hartnett ME, Weiter JJ, Gardts A, Jalkh AE (1992) Classification of retinal pigment epithelium detachments associated with drusen. Graefes Arch Clin Exp Ophthalmol 230:11–19
Hartnett ME, Weiter JJ, Staurenghi G, Elsner AE (1996) Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. Ophthalmology 103:2042–2053
Henderson BW, Donovan JM (1989) Release of prostaglandin Eqn.2 from cells by photodynamic treatment in vitro. Cancer Res 49:6896–6900
Husain D, Kramer M, Kenny AG, et al (1999) Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci 40:2322–2331
Kuhn D, Meunier I, Soubrane G, Coscas G (1995) Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol 113:1392–1398
Kuroiwa S, Arai J, Gaun S, et al (2003) Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina 2003 23:417–420
Lafaut BA, Aisenbrey S, Broecke CV, Bartz-Schmidt KU (2000) Clinicopathological correlation of deep retinal vascular anomalous complex in age-related macular degeneration. Br J Ophthalmol 84:1269–1274
Macular Photocoagulation Study Group (1993) Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings of two clinical trials. Arch Ophthalmol 111:1200–1209
Pece A, Introini U, Bottoni F, Brancato R (2001) Acute retinal pigment epithelial tear after photodynamic therapy. Retina 21:661–665
Rogers AH, Martidis A, Greenberg PB, Puliafito CA (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566–576
Schurig Fernandes LH, Freund KB, Yannuzzi LA, et al (2002) The nature of focal areas of hyperfluorescence or “hot spots” imaged with indocyanine green angiography. Retina 22:557–568
Silva RM, Faria de Abreu JR, Travassos A, Cunha-Vaz JG (2004) Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomosis. Graefes Arch Clin Exp Ophthalmol 242:368–376
Slakter JS, Yannuzzi LA, Schneider U, et al (2000) Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107:742–754
Spaide RF, Sorenson J, Maranan L (2003) Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110:1517–1525
Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials—TAP report 1. Arch Ophthalmol 117:1329–1345
Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials—TAP report 2. Arch Ophthalmol 119:198–207
Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (2002) Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Three-year results of an open-label extension of 2 randomized clinical trials—TAP report 5. Arch Ophthalmol 120:1307–1314
Verteporfin in Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2. Am J Ophthalmol 131:541–560
Verteporfin in Photodynamic Therapy Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia. Two-year results of a randomized clinical trial—VIP report 3. Ophthalmology 110:667–673
Yannuzzi LA (2002) Reply to letter. Retina 22:511–512
Yannuzzi LA, Negrao S, Iida T, Carlalho C, et al (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416–434
Yeo JH, Marcus S, Murphy RP (1988) Retinal pigment epithelial tears. Patterns and prognosis. Ophthalmology 95:8–13
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no financial interest in this study
Rights and permissions
About this article
Cite this article
Boscia, F., Parodi, M.B., Furino, C. et al. Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefe's Arch Clin Exp Ophthalmo 244, 1224–1232 (2006). https://doi.org/10.1007/s00417-005-0205-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-005-0205-2